Authors: GALLAGHER M ALLEN SL STEVENSON J HILLER K OMARA V VELAGAPUDI R MITCHELL E VILLALONA M VANECHO D JAKIMOWICZ K ALLEN LF FISCHKOFF S ODWYER PJ

Citation: M. Gallagher et al., PHASE-I TRIAL OF THE DOLASTATIN-15 ANALOG LU-103793 (CEMADOTIN) EVERYOTHER DAY FOR 3 DOSES, Annals of oncology, 9, 1998, pp. 386-386

Authors: VILLALONACALERO MA BAKER SD HAMMOND L AYLESWORTH C ECKHARDT SG KRAYNAK M FRAM R FISCHKOFF S VELAGAPUDI R TOPPMEYER D RAZVILLAS B JAKIMOWICZ K VANHOFF DD ROWINSKY E

Citation: Ma. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE WATER-SOLUBLE DOLASTATIN-15 ANALOG LU103793 IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2770-2779

Authors: FISCHKOFF S MARTIN K

Citation: S. Fischkoff et K. Martin, RESPONSE TO MORE IS NOT ALWAYS BETTER - A CASE FOR LOW-DOSE LEUCOVORIN, Journal of clinical oncology, 11(7), 1993, pp. 1434-1435